Clinical Trial: SWOG S1931

SWOG S1931

Status: New, Open

Phase III Trial of Immunotherapy-Based Combination Therapy with or Without Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma (PROBE Trial)

Eligible for screening study DCP 001